Deep Read: Zehn Wochen vom vertraulichen Brief bis zum Aus: So scheiterte der Milliarden-Plan von BASF
BASF-Chef Kamieth wollte mit Evonik einen global mächtigen Chemie-Champion schaffen. Doch sein Management unterschätzte den politischen Widerstand. Rekonstruktion eines Fehlschlags.
Düsseldorf, July 2022 – The BASF Supervisory Board convened at the end of July, with the company's boldest project to date on the table: the potential acquisition of Evonik, a rival in the German chemical industry and the second-largest player in the field. This ambitious plan, aimed at reshaping the German chemical sector under BASF's leadership, resonated with the supervisory board members.
However, one of them, Michael Vassiliadis, resigned from the board: he was the president of the IG BCE trade union, but his presence was viewed as a conflict of interest due to his membership on the Kuratorium of the Essener RAG Foundation, the largest investor in Evonik.
After approval from the supervisory board on July 23rd, the management was set to move forward with the project. Four months later, however, the BASF CEO Markus Kamieth's dream plan came to a halt. According to insiders, plans had been in motion for over a year, including a meeting in the Taunus region and a deadline that ultimately put too much pressure on the process.
The reconstruction reveals how an idea that had been meticulously prepared over months failed within just ten weeks. More than anything, it serves as a lesson on the power of political interests.
Rewritten by urgent.news; may contain errors — check the original.
Source: handelsblatt.com